Shareholder Alert: Levi & Korsinsky, LLP Notifies Shareholders of Cellular Biomedicine Group Inc. of Pendency of Class Action Lawsuit and a Lead Plaintiff Deadline of June 22, 2015 -- CBMG
(firmenpresse) - NEW YORK, NY -- (Marketwired) -- 04/29/15 -- The following statement is being issued by Levi & Korsinsky, LLP:
or otherwise acquired securities of (NASDAQ: CBMG)
that a securities class action lawsuit has been commenced in the United States District Court for the Northern District of California. If you purchased or otherwise acquired Cellular Biomedicine Group Inc. ("Cellular Biomedicine") securities between June 18, 2014 and April 7, 2015, . To get more information :
or contact Joseph E. Levi, Esq. either via email at or by telephone at (212) 363-7500, toll-free: (877) 363-5972.
The complaint alleges that, among other allegations, the Company used paid stock promoters to achieve its $500 million valuation, but failed to disclose the use of promoters in its regulatory filings.
On April 7, 2015, an article featured on Seeking Alpha alleged that the Company was engaged in a fraudulent scheme to mislead investors.
to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.
Levi & Korsinsky is a national firm with offices in New York, New Jersey, Connecticut and Washington D.C. The firm's attorneys have extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities and shareholder lawsuits. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:
Levi & Korsinsky, LLP
Eduard Korsinsky, Esq.
30 Broad Street - 24th Floor
New York, NY 10004
Tel: (212) 363-7500
Toll Free: (877) 363-5972
Fax: (212) 363-7171
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 29.04.2015 - 20:09 Uhr
Sprache: Deutsch
News-ID 389595
Anzahl Zeichen: 3117
contact information:
Town:
NEW YORK, NY
Kategorie:
Legal
Diese Pressemitteilung wurde bisher 191 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Shareholder Alert: Levi & Korsinsky, LLP Notifies Shareholders of Cellular Biomedicine Group Inc. of Pendency of Class Action Lawsuit and a Lead Plaintiff Deadline of June 22, 2015 -- CBMG"
steht unter der journalistisch-redaktionellen Verantwortung von
Levi & Korsinsky, LLP (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
